155 related articles for article (PubMed ID: 25180910)
1. Expression of THOP1 and its relationship to prognosis in non-small cell lung cancer.
Qi L; Li SH; Si LB; Lu M; Tian H
PLoS One; 2014; 9(9):e106665. PubMed ID: 25180910
[TBL] [Abstract][Full Text] [Related]
2. [Expression and significance of Snail and Claudin-3 in non-small cell lung cancer].
Li J; Tu Y; Jiang L; Xu H; Zhang S
Zhongguo Fei Ai Za Zhi; 2012 Oct; 15(10):583-90. PubMed ID: 23075682
[TBL] [Abstract][Full Text] [Related]
3. MACC1 overexpression predicts a poor prognosis for non-small cell lung cancer.
Wang Z; Li Z; Wu C; Wang Y; Xia Y; Chen L; Zhu Q; Chen Y
Med Oncol; 2014 Jan; 31(1):790. PubMed ID: 24310811
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
[TBL] [Abstract][Full Text] [Related]
5. Expression analysis of THOP1 in background liver, a prognostic predictive factor in hepatocellular carcinoma, extracted by multiarray analysis.
Nomoto S; Hishida M; Inokawa Y; Takano N; Kanda M; Nishikawa Y; Fujii T; Koike M; Sugimoto H; Kodera Y
Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S443-50. PubMed ID: 24604581
[TBL] [Abstract][Full Text] [Related]
6. [Expressions and significances of CRABPII and E-FABP in non-small cell lung cancer].
Liu Q; Wang S; Xu H; Zhang S
Zhongguo Fei Ai Za Zhi; 2013 Jan; 16(1):12-9. PubMed ID: 23327868
[TBL] [Abstract][Full Text] [Related]
7. [Expression of ezrin in human non-small cell lung cancer and its relationship with metastasis and prognosis].
Chen QY; Yan J; Hu HZ; Chen FY; Song J; Jiang ZY; Jiao DM; Wu YQ
Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):436-40. PubMed ID: 22967445
[TBL] [Abstract][Full Text] [Related]
8. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
[TBL] [Abstract][Full Text] [Related]
9. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.
Liao WT; Wang X; Xu LH; Kong QL; Yu CP; Li MZ; Shi L; Zeng MS; Song LB
Cancer; 2009 Apr; 115(7):1507-17. PubMed ID: 19170237
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of NKD1 increases the invasive potential of non-small-cell lung cancer and correlates with a poor prognosis.
Zhang S; Wang Y; Dai SD; Wang EH
BMC Cancer; 2011 May; 11():186. PubMed ID: 21599923
[TBL] [Abstract][Full Text] [Related]
11. LETM1 is a potential biomarker of prognosis in lung non-small cell carcinoma.
Piao L; Yang Z; Feng Y; Zhang C; Cui C; Xuan Y
BMC Cancer; 2019 Sep; 19(1):898. PubMed ID: 31500591
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of SOX9 in human non-small cell lung cancer progression and overall patient survival.
Zhou CH; Ye LP; Ye SX; Li Y; Zhang XY; Xu XY; Gong LY
J Exp Clin Cancer Res; 2012 Mar; 31(1):18. PubMed ID: 22385677
[TBL] [Abstract][Full Text] [Related]
14. Reduced expression of liver kinase B1 and Beclin1 is associated with the poor survival of patients with non-small cell lung cancer.
Jiang L; Liang X; Liu M; Wang W; Ma J; Guo Q; Han L; Yang C; Nan K
Oncol Rep; 2014 Nov; 32(5):1931-8. PubMed ID: 25175672
[TBL] [Abstract][Full Text] [Related]
15. [Expression of alpha-tubulin and MDR1 and their correlation with the biological features of non-small cell lung carcinoma].
Chen QY; Jiang ZY; Wu LJ; Zhang BY; Lu GH; Zhou JY
Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):278-82. PubMed ID: 20510079
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of STAT3 expression and its correlation with chemoresistance of non-small cell lung cancer cells.
Yin Z; Zhang Y; Li Y; Lv T; Liu J; Wang X
Acta Histochem; 2012 Feb; 114(2):151-8. PubMed ID: 21549414
[TBL] [Abstract][Full Text] [Related]
17. CHIP involves in non-small cell lung cancer prognosis through VEGF pathway.
Tingting Q; Jiao W; Qingfeng W; Yancheng L; Shijun YU; Zhaoqi W; Dongmei S; ShiLong W
Biomed Pharmacother; 2016 Oct; 83():271-276. PubMed ID: 27392029
[TBL] [Abstract][Full Text] [Related]
18. TFIIB-related factor 2 over expression is a prognosis marker for early-stage non-small cell lung cancer correlated with tumor angiogenesis.
Lu M; Tian H; Yue W; Li L; Li S; Qi L; Hu W; Gao C; Si L
PLoS One; 2014; 9(2):e88032. PubMed ID: 24523874
[TBL] [Abstract][Full Text] [Related]
19. [Expression of protein-tyrosine-phosphatase 1B in non-small-cell lung cancer and its prognostic significance].
Wang ZF; Liu HB; Yao YW; Chen FF; Song Y
Zhonghua Yi Xue Za Zhi; 2013 Oct; 93(38):3027-30. PubMed ID: 24417921
[TBL] [Abstract][Full Text] [Related]
20. [Correlation between expression of forkhead box M1 (FOXM1) and clinicopathological features and prognosis in patients with non-small cell lung cancer (NSCLC)].
Liu YQ; Guo RH; Liu LK; Gao W; Zhu CJ; Wei J; Shu YQ
Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):426-30. PubMed ID: 21875482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
